trending Market Intelligence /marketintelligence/en/news-insights/trending/eiCVla5ux4OS1zivXzCVxQ2 content esgSubNav
In This List

Abcam adds director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Abcam adds director

Abcam Plc appointed Giles Kerr to the board as a nonexecutive director, effective Dec. 12.

Kerris is a nonexecutive director at Arix Bioscience PLC, Isis Innovation Ltd. and Oxford Sciences Innovation.

Cambridge, U.K.-based Abcam produces and distributes research-grade antibodies and associated protein research tools worldwide.